Pharmaceutical Pricing and Reimbursement in the United Kingdom

被引:3
|
作者
D. Macarthur
机构
[1] Saffron Walden,
[2] England,undefined
来源
关键词
General Practitioner; National Health; National Health Service; Drug Cost; Regulation Scheme;
D O I
10.1007/s101980050010
中图分类号
学科分类号
摘要
引用
收藏
页码:47 / 50
页数:3
相关论文
共 50 条
  • [1] Pharmaceutical pricing and reimbursement in Spain
    J. Rovira
    J. Darbà
    The European Journal of Health Economics (HEPAC), 2001, 2 (1): : 39 - 43
  • [2] Pharmaceutical pricing and reimbursement in Finland
    Rinta S.
    The European Journal of Health Economics (HEPAC), 2001, 2 (3): : 128 - 135
  • [3] Pharmaceutical pricing and reimbursement reforms in Greece
    John Yfantopoulos
    The European Journal of Health Economics, 2008, 9 : 87 - 97
  • [4] Pharmaceutical pricing and reimbursement reforms in Greece
    Yfantopoulos, John
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2008, 9 (01): : 87 - 97
  • [5] Pricing and reimbursement of pharmaceutical products in France
    Friedeberg-Steward, B
    DRUG INFORMATION JOURNAL, 2000, 34 (04): : 1201 - 1205
  • [6] Pricing and Reimbursement of Pharmaceutical Products in France
    Beatrix Friedeberg-Steward
    Drug information journal : DIJ / Drug Information Association, 2000, 34 (4): : 1201 - 1205
  • [7] Challenges and opportunities for pharmaceutical pricing and reimbursement policies
    Sabine Vogler
    Nina Zimmermann
    Alessandra Ferrario
    Veronika J Wirtz
    Zaheer-Ud-Din Babar
    Journal of Pharmaceutical Policy and Practice, 8 (Suppl 1)
  • [8] Pharmaceutical pricing and reimbursement policies: perspectives for the future
    Andrew L Gray
    Journal of Pharmaceutical Policy and Practice, 8 (Suppl 1)
  • [9] Mexican pharmaceutical pricing and reimbursement policies, OECD, 2007
    Moise, Pierre
    Docteur, Elizabeth
    SALUD PUBLICA DE MEXICO, 2008, 50 : S504 - S510
  • [10] Innovation and Device Reimbursement United States vs United Kingdom
    Fajinmi, Oluwadamilola
    CHEST, 2023, 163 (01) : 36 - 37